Gliotoxins are secondary metabolites produced by certain strains of fungi, particularly those belonging to the genus *Aspergillus*. These compounds exhibit a wide range of biological activities, including immunosuppressive and cytotoxic effects. Gliotoxins have been studied for their potential in treating various diseases such as cancer, autoimmune disorders, and infections caused by fungal pathogens. Their unique structure and pharmacological properties make them promising candidates for further research and development in the pharmaceutical industry. Studies have shown that gliotoxins can modulate immune responses and inhibit proliferation of tumor cells, making them a focus of interest for both basic research and clinical applications.